Company News

Share this article:

Eli Lilly entered into a marketing collaboration with device-maker Medtronic to extend the reach of both companies' diabetes products. Marketing and sales operations at both companies will work together to “develop new educational resources and classes around the initiation and intensive management of insulin, insulin pump therapy and continuous glucose monitoring,” according to a joint release.

 

Novartis acquired the generic injectable cancer drugs business of Austria's EBEWE Pharma for $1.2 billion, cash. EBEWE's products will be incorporated into Novartis's generics unit, Sandoz, which will expand to create a new unit in Unterach, Austria, according to a statement.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.